Discover
MIST
Milestone Pharmaceuticals Inc.
1.32
2 x 0.97
2 x 1.68
bid
ask
-
0.02
1.49%
2 @ 07:41 AM
1.31 -0.01 (0.76%)
| Ytd | -34.65% | |
| 1y | -29.79% |
1.31
day range
1.35
1.00
52 week range
3.06
| Open | 1.35 | Prev Close | 1.34 | Low | 1.31 | High | 1.35 | Mkt Cap | 164.34M |
| Vol | 1.01M | Avg Vol | 1.78M | EPS | -0.64 | P/E | N/A | Forward P/E | -2.15 |
| Beta | 1.73 | Short Ratio | 2.46 | Inst. Own | 57.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.53 | 200-d Avg | 1.84 | 1yr Est | 10.25 |
| Income Statement | |||
| Total Revenue | 238.00K | ||
| Revenues (USD) | 238.00K | ||
| Cost of Revenue | 14.00K | ||
| Gross Profit | 224.00K | ||
| Operating Expenses | 23.89M | ||
| Research and Development Expense | 3.25M | ||
| Selling, General and Administrative Expense | 4.82M | ||
| Operating Income | -23.66M | ||
| Interest Expense | 4.14M | ||
| Net Income | -26.07M | ||
| Net Income Common Stock | -26.07M | ||
| Net Income Common Stock (USD) | -26.07M | ||
| Consolidated Income | -26.07M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -21.93M | ||
| Earning Before Interest & Taxes (USD) | -21.93M | ||
| Weighted Average Shares | 130.29M | ||
| Weighted Average Shares Diluted | 130.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 71.32M | ||
| Cash and Equivalents (USD) | 71.32M | ||
| Investments | 112.90M | ||
| Investments Current | 112.90M | ||
| Trade and Non-Trade Receivables | 4.58M | ||
| Current Assets | 192.25M | ||
| Property, Plant & Equipment Net | 1.48M | ||
| Total Assets | 193.73M | ||
| Debt Current | 659.00K | ||
| Total Debt | 137.33M | ||
| Current Liabilities | 20.94M | ||
| Debt Non-Current | 136.67M | ||
| Total Liabilities | 157.69M | ||
| Accumulated Retained Earnings (Deficit) | -456.67M | ||
| Shareholders Equity | 36.05M | ||
| Shareholders Equity (USD) | 36.05M | ||
| Assets Non-Current | 1.48M | ||
| Total Debt (USD) | 137.33M | ||
| Deferred Revenue | 416.00K | ||
| Inventory | 1.83M | ||
| Liabilities Non-Current | 136.74M | ||
| Trade and Non-Trade Payables | 10.02M | ||
| Tax Assets | 425.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 56.00K | ||
| Net Cash Flow from Financing | 94.35M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.73M | ||
| Capital Expenditure | -45.00K | ||
| Issuance (Purchase) of Equity Shares | 19.36M | ||
| Issuance (Repayment) of Debt Securities | 74.99M | ||
| Net Cash Flow from Investing | -80.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -79.98M | ||
| Net Cash Flow from Operations | -16.05M | ||
| Share Based Compensation | 1.28M | ||